drugset / Trial / NCT01675570
A Study of RX-10045 in the Treatment of Dry Eye Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary purpose of this study is to assess the efficacy, tolerability and safety of RX-10045 Ophthalmic Solution in patients with Dry Eye Disease.
Timeline
- Start
- 2012-08
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NAVAMEPENT | Small molecule | 0.09 % | Other |